Melanoma differentiation-associated gene-7/IL-24 gene enhances NF-KB activation and suppresses apoptosis induced by TNF

被引:20
作者
Aggarwal, S
Takada, Y
Mhashilkar, AM
Sieger, K
Chada, S
Aggarwal, BB
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA
[2] Introgen Therapeut, Houston, TX 77030 USA
关键词
D O I
10.4049/jimmunol.173.7.4368
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Melanoma differentiation-associated gene-7 (mda-7), also referred to as IL-24, is a novel growth regulatory cytokine that has been shown to regulate the immune system by inducing the expression of inflammatory cytokines, such as TNF, IL-1, and IL-6. Whether the induction of these cytokines by MDA-7 is mediated through activation of NF-kappaB or whether it regulates cytokine signaling is not known. In the present report we investigated the effect of MDA-7 on NF-kappaB activation and on TNF-induced NF-kappaB activation and apoptosis in human embryonic kidney 293 cells. Stable or transient transfection with mda-7 into 293 cells failed to activate NF-kappaB. However, TNF-induced NF-kappaB activation was significantly enhanced in mda-7-transfected cells, as indicated by DNA binding, p65 translocation, and NF-kappaB-dependent reporter gene expression. Mda-7 transfection also potentiated NF-kappaB reporter activation induced by TNF receptor-associated death domain and TNF receptor-associated factor-2. Cytoplasmic MDA-7 with deleted signal sequence was as effective as full-length MDA-7 in potentiating TNF-induced NF-kappaB reporter activity. Secretion of MDA-7 was not required for the potentiation of TNF-induced NF-kappaB activation. TNF-induced expression of the NF-kappaB-regulated gene products cyclin D1 and cyclooxygenase-2, were significantly up-regulated by stable expression of MDA-7. Furthermore, MDA-7 expression abolished TNF-induced apoptosis, and suppression of NF-kappaB by IkappaBalpha kinase inhibitors enhanced apoptosis. Overall, our results indicate that stable or transient MDA-7 expression alone does not substantially activate NF-kappaB, but potentiates TNF-induced NF-kappaB activation and NF-kappaB-regulated gene expression. Potentiation of NF-kappaB survival signaling by MDA-7 inhibits TNF-mediated apoptosis.
引用
收藏
页码:4368 / 4376
页数:9
相关论文
共 54 条
[1]  
AGGARWAL BB, 1987, J BIOL CHEM, V262, P10000
[2]  
Aggarwal BB, 1996, CANCER RES, V56, P5156
[3]   Signalling pathways of the TNF superfamily: A double-edged sword [J].
Aggarwal, BB .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (09) :745-756
[4]   CHARACTERIZATION OF RECEPTORS FOR HUMAN-TUMOR NECROSIS FACTOR AND THEIR REGULATION BY GAMMA-INTERFERON [J].
AGGARWAL, BB ;
EESSALU, TE ;
HASS, PE .
NATURE, 1985, 318 (6047) :665-667
[5]   An essential role for NF-kappa B in preventing TNF-alpha-induced cell death [J].
Beg, AA ;
Baltimore, D .
SCIENCE, 1996, 274 (5288) :782-784
[6]  
Bonizzi G, 1997, J IMMUNOL, V159, P5264
[7]   PKR stimulates NF-κB irrespective of its kinase function by interacting with the IκB kinase complex [J].
Bonnet, MC ;
Weil, R ;
Dam, E ;
Hovanessian, AG ;
Meurs, EF .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (13) :4532-4542
[8]   Adenoviral transfer of mda-7 leads to BAX up-regulation and apoptosis in mesothelioma cells, and is abrogated by over-expression of BCL-XL [J].
Cao, XX ;
Mohuiddin, I ;
Chada, S ;
Mhashilkar, AM ;
Ozvaran, MK ;
McConkey, DJ ;
Miller, SD ;
Daniel, JC ;
Smythe, WR .
MOLECULAR MEDICINE, 2002, 8 (12) :869-876
[9]   The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24 [J].
Caudell, EG ;
Mumm, JB ;
Poindexter, N ;
Ekmekcioglu, S ;
Mhashilkar, AM ;
Yang, XHH ;
Retter, MW ;
Hill, P ;
Chada, S ;
Grimm, EA .
JOURNAL OF IMMUNOLOGY, 2002, 168 (12) :6041-6046
[10]   MDA-7/IL-24 is a unique cytokine-tumor suppressor in the IL-10 Family [J].
Chada, S ;
Sutton, RB ;
Ekmekcioglu, S ;
Ellerhorst, J ;
Mumm, JB ;
Leitner, WW ;
Yang, HY ;
Sahin, AA ;
Hunt, KK ;
Fuson, KL ;
Poìndexter, N ;
Roth, JA ;
Ramesh, R ;
Grimm, EA ;
Mhashilkar, AM .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2004, 4 (05) :649-667